Tue, April 24, 2012
[ Tue, Apr 24th 2012 ]: Market Wire
Kensey Nash Introduces A Novel Biomaterial, Meso .. Peritoneum, For Plastic And Reconstructive Surge
[ Tue, Apr 24th 2012 ]: Market Wire
Law Office of Brodsky amp;; Smith, LLC Announces Investigation of Ardea Biosciences, Inc.
[ Tue, Apr 24th 2012 ]: Market Wire
Life Technologies vai construir unidade adicional .. e de US$ 20 milhes para cultura celular na Esccia
[ Tue, Apr 24th 2012 ]: Market Wire
Humana Military Named Title Sponsor of 23rd Annua .. Navy Daysa Fleet Week in Port Everglades, Florida
[ Tue, Apr 24th 2012 ]: Market Wire
Dr. Reddyas Announces the Launch of Olanzapine Tablets
[ Tue, Apr 24th 2012 ]: Market Wire
Ardea Biosciences, Inc. Board of Directors Under .. reaches of Fiduciary Duty by Law Offices of Howar
[ Tue, Apr 24th 2012 ]: Market Wire
ProMetic Signs a $1.4 Million Agreement With European Biotech Company
[ Tue, Apr 24th 2012 ]: Market Wire
An Unprecedented Data Point, The Single-Treatment .. patitis C Virus (HCV) by the Aethlon Hemopurifier
[ Tue, Apr 24th 2012 ]: Market Wire
Graymark Healthcare Opens Four New Facilities for Sleep Medicine Services
[ Tue, Apr 24th 2012 ]: Market Wire
Biotech Investment Banker Leouzon to Join IMV Board
[ Tue, Apr 24th 2012 ]: Market Wire
JDRF Announces Research Collaboration with Dexcom .. 9;Smart Transmitterquot;; Technology to Ac
[ Tue, Apr 24th 2012 ]: Market Wire
Les rsultats positifs de l'essai clinique de phas .. acit et lainnocuit du BG-12 sous forme orale dans
[ Tue, Apr 24th 2012 ]: Market Wire
I risultati positivi dello studio clinico CONFIRM .. acia e la sicurezza del farmaco orale BG-12 per l
[ Tue, Apr 24th 2012 ]: Market Wire
Positive Results from Phase 3 CONFIRM Clinical Tr .. cy and Safety of Oral BG-12 in Multiple Sclerosis
[ Tue, Apr 24th 2012 ]: Market Wire
Mylan Launches Generic Version of Zyprexa Tablets
[ Tue, Apr 24th 2012 ]: Market Wire
ICON reports a 10% increase in first quarter 2012 .. r on year, EPS of 15 cents, net new business awar
[ Tue, Apr 24th 2012 ]: Market Wire
Simcere Pharmaceutical Group to Announce First Qu .. 2012 Financial Results on Wednesday, May 9, 2012
[ Tue, Apr 24th 2012 ]: Market Wire
Ironwood?Forest??FDA??Linaclotide???????2012?9?
[ Tue, Apr 24th 2012 ]: Market Wire
Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
[ Tue, Apr 24th 2012 ]: Market Wire
OMONTYS (Peginesatide) Injection Now Available fo .. e (CKD) Patients on Dialysis in the United States
[ Tue, Apr 24th 2012 ]: Market Wire
Illumina Launches MyGenome App for iPad
[ Tue, Apr 24th 2012 ]: Market Wire
Orthofix International Announces Signing of Agree .. Business Unit to Water Street Healthcare Partners
Mon, April 23, 2012
[ Mon, Apr 23rd 2012 ]: Market Wire
Ironwood et Forest annoncent le prolongement par .. 'examen portant sur le linaclotide septembre 2012
[ Mon, Apr 23rd 2012 ]: Market Wire
Ironwood y Forest anuncian que la FDA ha prolonga .. isin para la linaclotida hasta septiembre de 2012
[ Mon, Apr 23rd 2012 ]: Market Wire
A Forward Look, the Year Ahead -- Featured Resear .. a Pharmaceuticals, Inc. and AstraZeneca plc (ADR)
[ Mon, Apr 23rd 2012 ]: Market Wire
biOasis Closes Private Placement for $2,484,000 Gross Proceeds
[ Mon, Apr 23rd 2012 ]: Market Wire
Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
[ Mon, Apr 23rd 2012 ]: Market Wire
Herborium Group Announces 100 Million Share Buyback
[ Mon, Apr 23rd 2012 ]: Market Wire
Nephros Appoints John C. Houghton as President and Chief Executive Officer
[ Mon, Apr 23rd 2012 ]: Market Wire
Catasys, Inc. Announces $3.4 Million Private Placement Led by Affiliate of Chief Executive Officer
[ Mon, Apr 23rd 2012 ]: Market Wire
Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotusa" Aortic Valve System
[ Mon, Apr 23rd 2012 ]: Market Wire
Nuevos datos presentados en el 64 Congreso Anual .. Biogen Idec para ofrecer terapias prometedoras p
[ Mon, Apr 23rd 2012 ]: Market Wire
Cynapsus Therapeutics Appoints Dr. Abraham Lieberman to Clinical Advisory Board
[ Mon, Apr 23rd 2012 ]: Market Wire
Alnylam Elects Dr. Dennis Ausiello to its Board of Directors and Scientific Advisory Board
[ Mon, Apr 23rd 2012 ]: Market Wire
International Stem Cell Corporation Appoints MZ Group as its Investor Relations Firm
[ Mon, Apr 23rd 2012 ]: Market Wire
Five Star Quality Care, Inc. First Quarter Conference Call Scheduled for Monday, April 30th
[ Mon, Apr 23rd 2012 ]: Market Wire
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clin .. n Society of Cataract and Refractive Surgery (ASC
[ Mon, Apr 23rd 2012 ]: Market Wire
Ironwood und Forest melden Verlngerung des Prfung .. traums fr Linaclotid durch FDA bis September 2012
[ Mon, Apr 23rd 2012 ]: Market Wire
Natus Medical to Hold Conference Call on April 23
[ Mon, Apr 23rd 2012 ]: Market Wire
CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
[ Mon, Apr 23rd 2012 ]: Market Wire
NeuroMetrix to Support Study at the Joslin Diabetes Center
[ Mon, Apr 23rd 2012 ]: Market Wire
Delcath Systems, Inc. Secures $20 Million Credit Facility
[ Mon, Apr 23rd 2012 ]: Market Wire
OncoSec ElectroChemotherapy Demonstrates Potentia .. tive to Surgery for Treating Head and Neck Cancer
[ Mon, Apr 23rd 2012 ]: Market Wire
PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
Sun, April 22, 2012
[ Sun, Apr 22nd 2012 ]: Market Wire
AstraZeneca to Acquire Ardea Biosciences for $1.2 .. oduct Lesinurad in Phase III Development for Gout
[ Sun, Apr 22nd 2012 ]: Market Wire
The Law Firm of Levi amp;; Korsinsky Notif .. Their Investment in China Sky One Medical, Inc. o
[ Sun, Apr 22nd 2012 ]: Market Wire
The Law Firm of Levi & Korsinsky Notifies Investo .. tment in China Sky One Medical, Inc. of Class Act
Sat, April 21, 2012
[ Sat, Apr 21st 2012 ]: Market Wire
Auf der 64. AAN-Jahrestagung prsentierte Daten un .. on Biogen Idec in der Entwicklung vielversprechen

Baxter to Webcast Annual Meeting of Shareholders

DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE:BAX) will webcast its annual meeting of shareholders on Tuesday, May 8, 2012, at 9:00 a.m. Central Time.

This call is being webcast by Thomson Reuters and can be accessed along with accompanying slides from Baxteras Web site at [ www.baxter.com ]. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxteras permission.

Baxter International Inc. innovates, develops, manufactures and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The companyas diverse portfolio is focused on treatments that save and sustain lives. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to research and create products that advance patient care worldwide.